How does CDMO claims history affect insurance renewal pricing?

Specialty life-sciences carriers underwrite renewals based on five-year claims history, sometimes ten-year for products liability. The components reviewed: number of claims, average severity, total incurred (paid plus reserves), claim categorization (products defect vs contamination vs labeling vs sterility), open vs closed status, and litigation versus settled.

A "clean" history is generally zero or one minor claim ($25K or less incurred) over the prior five years. Two or more claims at any severity, or a single claim above $250K, triggers heightened underwriting and typically a renewal premium step-up.

A single $250K-$1M products liability claim typically produces a 20-50% renewal premium increase for the affected line, with the increase persisting two to three renewal cycles before the claim "rolls off" the five-year window. Severity above $1M can produce 100%+ increases or non-renewal.

Multiple claims in a five-year window produce compounding effects. Three or more claims in five years typically forces a market change — the incumbent carrier non-renews and the operator places in the next-tier market at materially higher pricing.

Several practices materially affect the underwriter's perception of a prior claim: (1) detailed root cause analysis documentation showing the operator understands what happened and what was changed in response, (2) corrective action evidence (process changes, training, equipment upgrades, audit results), (3) sponsor communication evidence showing the operator handled the claim transparently, (4) post-claim quality system metrics demonstrating improvement.

Operators that go into renewal with a thorough corrective-action story typically pay less premium uplift than operators who present only the loss numbers.

A common decision at renewal after a claim: stay with the incumbent and accept the increase, or shop the market. The shopping calculus depends on several factors: (1) how the incumbent has handled the claim through investigation, defense, and settlement (carrier behavior matters as much as carrier price), (2) what the market quote actually looks like (sometimes the market provides 0-10% relief, sometimes 40%+ relief), (3) the operator's relationship with the incumbent and the value of continuity.

A market change after a meaningful claim is sometimes the right call but can also be a downgrade — the operator may go from a specialty life-sciences market to a generalist commercial market with worse form quality. Form quality often matters more than premium dollars at this decision point.

Claims history is the single most controllable input to long-term insurance economics for a CDMO or 503B. A clean five-year window unlocks specialty market access and competitive pricing; a noisy five-year window forces operators into the next-tier markets at materially higher cost. Quality system investment and claims-prevention discipline have insurance-economics implications that often exceed the premium savings achievable through broker shopping.